Metoprolol adverse events and literature analyses: case/non-case analyses using the FDA Adverse Event Reporting System (FAERS)

<p>In recent years, β-blockers such as metoprolol have been upgraded to first-line antihypertensive drugs. However, metoprolol demonstrates poor prognosis effects on diseases such as stroke. Further clinical application may expand the possibility of its related adverse reactions. Currently, th...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Yikuan Du (16324215) (author)
مؤلفون آخرون:	Mengting Zhang (753780) (author), Ziyi Luo (8058782) (author), Zhonghan Liang (20471606) (author), Weijian Liang (6816539) (author), Zhixing Chen (1303152) (author), Ruiyun Fan (20471609) (author), Yin Huang (179237) (author), Jiaqi Li (220961) (author), Mianda Hu (20393949) (author), Jiahui Li (646449) (author), Jinfeng Zhu (589893) (author), Weichui Zhang (16324227) (author), Yi Liu (36759) (author), Chun Yang (251691) (author)
منشور في:	2024
الموضوعات:	Biochemistry Medicine Genetics Pharmacology Biotechnology Immunology Science Policy Infectious Diseases Biological Sciences not elsewhere classified Metoprolol FDA Adverse Events Reporting System adverse events disproportionality analysis pharmacovigilance
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Metoprolol adverse events and literature analyses: case/non-case analyses using the FDA Adverse Event Reporting System (FAERS)

مواد مشابهة